1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Debbie Daniels
Our people

Dr Debbie Daniels

Research Officer

Deborah.Daniels@burnet.edu.au
Dr Debbie Daniels

Background

Debbie joined the Antiviral Immunity Group led by Dr Gabriela Khoury in November 2023 as a Research Officer. Having obtained her PhD from the University of Bristol in 2020, she went on to pursue a 3-year postdoc position in Professor Jan Frayne’s group. This research focused on developing erythroid progenitor cell lines as model systems of genetic red blood cell diseases, including beta thalassemia and sickle cell disease.

Qualifications

  • 2020: PhD, University of Bristol, UK
  • 2016: MSc by Research, University of Bristol, UK
  • 2013: BSc (Hons), University of Bristol, UK

Appointments

  • 2023: Policy Consultant for the Biochemical Society, UK
  • 2022: Invited speaker for the British Blood Transfusion Society Conference, UK.
  • 2022: Invited speaker for the Red Cell Club Meeting, USA

Positions

•    2022-ongoing: Consultant for Scarlet Therapeutics Ltd. 
•    2020-2023: Research Associate, Frayne Lab, University of Bristol, UK

Current projects

Improving care for people with lupus: temporary withholding of immunosuppressant

Improving care for people with lupus: temporary withholding of immunosuppressant

We're testing the use of mycophenolate treatments for lupus.

Profiling immune responses in paediatric and high-risk populations to the COVID-19 virus (PROPHECY)

Profiling immune responses in paediatric and high-risk populations to the COVID-19 virus (PROPHECY)

This study will evaluate immune responses after COVID-19 infection or vaccination in healthy and vulnerable people.

On this page